Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

Clinical trial NCT01340794 · TERMINATED

Trial details

NCT number: NCT01340794
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Extra-Adrenal Paraganglioma Metastatic Adrenal Gland Pheochromocytoma Paraganglioma Recurrent Adrenal Gland Pheochromocytoma

Start date: 2011-05-01
Primary completion: 2014-11-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.